Jeff Cottrell Email and Phone Number
Jeff Cottrell work email
- Valid
- Valid
- Valid
Jeff Cottrell personal email
Jeff Cottrell phone numbers
Accomplished neuroscientist, strategic thinker, and scientific and executive leader with extensive drug discovery experience, including 20 years in leading teams for the development of innovative approaches for therapeutic development.• Drug discovery project leadership, including cross-functional projects in a matrix environment • Scientific team leadership and development, including management of groups of multiple Ph.D. scientists • Alliance and collaboration management, including corporate, non-for-profit, and academic collaborations• Strategic planning, focused on developing portfolios for neurodegenerative and neuropsychiatric disorders • Successful fund raising through the development and presentation of drug discovery strategic plans to potential industry partners and acquisition of philanthropy and federal grants• Intellectual property development, including patent drafting and claim development
-
Interim Chief Scientific OfficerScn2A- The Familiescn2A FoundationCambridge, Ma, Us -
Senior PartnerBracken Oct 2024 - PresentNewtown, Pennsylvania, UsThe Bracken Group is a Life Sciences advisory and consulting firm that specializes in providing a wide range of solutions to companies in the pharmaceutical, biotech, and medical device industries. We offer services such as consulting, regulatory affairs, clinical development, market access, marketing, data & analytics, M&A, commercial due diligence, and commercialization strategy. https://www.thebrackengroup.com -
Co-Founder And Chief Executive OfficerStealth Newco Sep 2024 - PresentStealth newco focused on mechanism-based therapeutics for psychiatric and neurodegenerative disease.
-
Scientific Advisor; Tasco (Team For Accelerating Science And Clinical Outcomes)Scn2A- The Familiescn2A Foundation Mar 2024 - PresentEast Longmeadow, Ma, Us
-
Independent Biotechnology And Neuroscience ConsultantJcneuro Consulting, Llc Apr 2024 - Oct 2024Providing expert consultation on neuroscience strategy, organizational design, in vitro pharmacology, and other aspects of CNS therapeutic development. If you are seeking my consulting services, I am now exclusively available through The Bracken Group and reach me at jcottrell@thebrackengroup.com.
-
Head Of Systems NeuroscienceNovartis Institutes For Biomedical Research (Nibr) Dec 2021 - Apr 2024Basel, Baselstadt, Ch• Served as unit head overseeing drug discovery and development programs targeting neurodevelopment, psychiatry, and neurodegeneration using multiple therapeutic modalities, including small molecule, AAV, and siRNA• Developed and implemented a novel precision psychiatric and neurodegenerative disease drug discovery strategy rooted in genetics and based on targeting neural circuitry • Led stakeholder management efforts to ensure the adoption of this novel strategy for drug discovery and development• Oversaw biology efforts in advancing psychiatric disease clinical programs through early-stage clinical trials, including mechanism of action research and human biomarker development• Directly led and mentored a team of up to twenty-nine scientists of various stages of career development, including reorganizing the group into a matrix structure for flexibility and efficiency• Served as member of the Neuroscience Leadership Team to determine the strategic direction of the department of 140 scientists • Contributed to various institute-wide initiatives including the NIBR retreat planning committee and academic grant review -
Senior Director, NeurobiologySerqet Therapeutics Jan 2021 - Sep 2021• Established translational biology team and program to advance targets from genetics and computational selection into drug discovery for neurodegenerative disorders• Led novel biochemical and cell-based screening assays development for drug discovery programs• Developed and implement strategic plans for linking genetic signatures to disease pathology • Selected targets for advancement into validation and drug discovery activities
-
Vice President Of DiscoveryDelix Therapeutics May 2020 - Dec 2020Boston, Massachusetts, Us• As first hire, determined the scientific strategic direction of a nascent startup company focused on neuropsychiatric disease• Developed virtual drug discovery program through the identification of appropriate CROs and the establishment of partnerships • Collaborated with medicinal chemistry team to implement drug discovery program• Established company scientific goals and timelines and allocated a $8.5M budget • Developed strategy for corporate development including hiring plan, organizational structure, branding, and funding raising activities• Managed $8M research budget -
Director Of Translational ResearchBroad Institute Of Mit And Harvard Jun 2015 - May 2020Cambridge, Ma, UsStanley Center for Psychiatric Research• Led a multi-disciplinary group for the translation of genetics research into therapeutic and biomarker projects• Applied strategic skills to organize a cohesive target identification and drug discovery team from different disparate legacy groups• Generated a robust and comprehensive drug discovery and biomarker portfolio through the initiation of new projects and ending others through scientifically based no-go decisions• Established a matrix organization-type environment within the therapeutics team with clear goals and timelines for optimum project progression• Led and mentored a group of ten scientists tasked with responsibilities from genetics-based target discovery to in vitro assay development and compound screening• Worked collaboratively across the Stanley Center, the Broad Institute, and affiliated universities to advance psychiatric disease research through establishing multiple academic collaborations• Awarded multiple NIH grants, including as co-principal investigator of a multi-year R01 supporting a novel schizophrenia therapeutics project• Led a collaboration with a pharma company ($1.5M/year) for the mechanism of action analysis of a potential novel psychiatric disease therapeutic developed at the Stanley Center• Manage a $12M budget, develop annual goals and timelines for projects, and track progress -
Director Of In Vitro Discovery And PharmacologyGalenea Aug 2004 - Jun 2015Director (October 2013-Present)Associate Director (October 2011-September 2013)• Led group developing and conducting phenotypic screening assays of synaptic function for CNS diseases• Served as project leader for drug discovery programs for schizophrenia and neurodegenerative disorders utilizing novel synaptic transmission assay technology• Performed alliance management for multiple successful collaborations• Managed multiple academic collaborations and studies performed at CROs and service providers• Contributed to development of corporate strategic vision, investor presentations, and scientific proposals to funding partners and collaboratorsSenior Scientist (January 2008-September 2011)• Led group for the development of cell-based assays for multiple central nervous system disorders• Led the development of an assay technology for the identification of modulators of synaptic function in primary neuronal cultures− Managed collaboration with engineering firm for screening technology construction− Led the transfer of a copy of the screening technology to partner’s research facility• Performed research on CNS disease mechanisms and target validation• Managed research collaboration with leading academic researcher• Led organization and writing of awarded NIH grant ($4.5M/3 years)Scientist (January 2006-December 2007)Associate Scientist (August 2004-December 2005)• Led group performing target identification and disease mechanism research for schizophrenia• Characterized expression and function of a gene associated with schizophrenia• Developed a phenotypic primary neuron screening assay for the discovery of novel treatments for schizophrenia• Managed two academic collaborations
Jeff Cottrell Skills
Jeff Cottrell Education Details
-
Massachusetts Institute Of TechnologyNeuroscience -
Harvard UniversityPsychology
Frequently Asked Questions about Jeff Cottrell
What company does Jeff Cottrell work for?
Jeff Cottrell works for Scn2a- The Familiescn2a Foundation
What is Jeff Cottrell's role at the current company?
Jeff Cottrell's current role is Interim Chief Scientific Officer.
What is Jeff Cottrell's email address?
Jeff Cottrell's email address is co****@****mit.edu
What is Jeff Cottrell's direct phone number?
Jeff Cottrell's direct phone number is +161737*****
What schools did Jeff Cottrell attend?
Jeff Cottrell attended Massachusetts Institute Of Technology, Harvard University.
What skills is Jeff Cottrell known for?
Jeff Cottrell has skills like Neuroscience, Drug Discovery, Pharmacology, Cell, Assay Development, Biochemistry, Lead Change, Electrophysiology, Biomarker Discovery, High Throughput Screening, Mass Spectrometry, Protein Chemistry.
Who are Jeff Cottrell's colleagues?
Jeff Cottrell's colleagues are Amanda Gale, Leah Schust Myers.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial